Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
123i-mip-1072 (1 trial)
capromab pendetide (Prostascint) (1 trial)
Prostatic Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (2 total)